106 related articles for article (PubMed ID: 10383720)
1. H-cadherin expression in breast cancer.
Takeuchi T; Misaki A; Chen BK; Ohtsuki Y
Histopathology; 1999 Jul; 35(1):87-8. PubMed ID: 10383720
[No Abstract] [Full Text] [Related]
2. Altered mucin expression is a field change that accompanies mucinous (colloid) breast carcinoma histogenesis.
O'Connell JT; Shao ZM; Drori E; Basbaum CB; Barsky SH
Hum Pathol; 1998 Dec; 29(12):1517-23. PubMed ID: 9865841
[TBL] [Abstract][Full Text] [Related]
3. Double immunostaining with p63 and high-molecular-weight cytokeratins distinguishes borderline papillary lesions of the breast.
Ichihara S; Fujimoto T; Hashimoto K; Moritani S; Hasegawa M; Yokoi T
Pathol Int; 2007 Mar; 57(3):126-32. PubMed ID: 17295644
[TBL] [Abstract][Full Text] [Related]
4. [Papillary lesions of the breast].
Ni YB; Tse GM
Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):721-6. PubMed ID: 24447546
[No Abstract] [Full Text] [Related]
5. Clinicopathologic and prognostic evaluation of invasive breast carcinoma molecular subtypes and GATA3 expression.
Demir H; Turna H; Can G; Ilvan S
J BUON; 2010; 15(4):774-82. PubMed ID: 21229645
[TBL] [Abstract][Full Text] [Related]
6. Cellular expression of growth hormone and prolactin receptors in human breast disorders.
Mertani HC; Garcia-Caballero T; Lambert A; Gérard F; Palayer C; Boutin JM; Vonderhaar BK; Waters MJ; Lobie PE; Morel G
Int J Cancer; 1998 Apr; 79(2):202-11. PubMed ID: 9583737
[TBL] [Abstract][Full Text] [Related]
7. Expression of E-cadherin in normal, hyperplastic and neoplastic feline mammary tissue.
Dias Pereira P; Gärtner F
Vet Rec; 2003 Sep; 153(10):297-302. PubMed ID: 14509576
[TBL] [Abstract][Full Text] [Related]
8. P53 expression in patients with malignant and benign breast diseases.
Kalogeraki A; Panayiotides J; Tamiolakis D; Tzardi M; Chaniotis V; Chalkiadakis G; Melissas J; Stiftsis D; Kanavaros P; Delides GS
Anticancer Res; 2000; 20(3A):1801-5. PubMed ID: 10928110
[TBL] [Abstract][Full Text] [Related]
9. Expression of ghrelin is correlated to a favorable outcome in invasive breast cancer.
Grönberg M; Fjällskog ML; Jirström K; Janson ET
Acta Oncol; 2012 Mar; 51(3):386-93. PubMed ID: 22067021
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of MAP1LC3A and MAP1LC3B protein in breast carcinoma tissues.
Othman EQ; Kaur G; Mutee AF; Muhammad TS; Tan ML
J Clin Lab Anal; 2009; 23(4):249-58. PubMed ID: 19623642
[TBL] [Abstract][Full Text] [Related]
11. HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome.
Trastour C; Benizri E; Ettore F; Ramaioli A; Chamorey E; Pouysségur J; Berra E
Int J Cancer; 2007 Apr; 120(7):1451-8. PubMed ID: 17245699
[TBL] [Abstract][Full Text] [Related]
12. E-cadherin status in breast cancer correlates with histologic type but does not correlate with established prognostic parameters.
Qureshi HS; Linden MD; Divine G; Raju UB
Am J Clin Pathol; 2006 Mar; 125(3):377-85. PubMed ID: 16613340
[TBL] [Abstract][Full Text] [Related]
13. [Relationship of ezrin protein expression to the carcinogenesis and prognosis of infitrating breast ductal carcinoma].
Ma L; Zhang XH; Xing LX; Li YH; Wang XL; Wang YJ
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):279-83. PubMed ID: 18788632
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical study of TGF-alpha, TGF-beta1, EGFR, and IGF-1 expression in human breast carcinoma.
Pilichowska M; Kimura N; Fujiwara H; Nagura H
Mod Pathol; 1997 Oct; 10(10):969-75. PubMed ID: 9346175
[TBL] [Abstract][Full Text] [Related]
15. The significance of N-cadherin expression in breast cancers: an evolving story.
Fadare O
South Med J; 2008 May; 101(5):459-60. PubMed ID: 18414148
[No Abstract] [Full Text] [Related]
16. Ki-67 is a prognostic marker for hormone receptor positive tumors.
Pérez-López ME; García-Gómez J; Alves MT; Paradela A; García-Mata J; García-Caballero T
Clin Transl Oncol; 2016 Oct; 18(10):996-1002. PubMed ID: 26742937
[TBL] [Abstract][Full Text] [Related]
17. Costimulatory molecule OX40/OX40L expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
Xie F; Wang Q; Chen Y; Gu Y; Mao H; Zeng W; Zhang X
Pathol Res Pract; 2010 Nov; 206(11):735-9. PubMed ID: 20634005
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma.
Zheng WQ; Looi LM; Cheah PL
Pathology; 2001 Aug; 33(3):303-6. PubMed ID: 11523929
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of human arrest-defective 1 protein is correlated with metastatic phenotype and poor prognosis in breast cancer.
Wang ZH; Gong JL; Yu M; Yang H; Lai JH; Ma MX; Wu H; Li L; Tan DY
Asian Pac J Cancer Prev; 2011; 12(8):1973-7. PubMed ID: 22292636
[TBL] [Abstract][Full Text] [Related]
20. Interplay between membrane lipid peroxidation, transglutaminase activity, and cyclooxygenase 2 expression in the tissue adjoining to breast cancer.
Balestrieri ML; Dicitore A; Benevento R; Di Maio M; Santoriello A; Canonico S; Giordano A; Stiuso P
J Cell Physiol; 2012 Apr; 227(4):1577-82. PubMed ID: 21678409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]